These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1166 related articles for article (PubMed ID: 24946958)
101. Use of percutaneous radiofrequency ablation in pulmonary metastases from renal cell carcinoma. Shu Yan Huo A; Lawson Morris D; King J; Glenn D Ann Surg Oncol; 2009 Nov; 16(11):3169-75. PubMed ID: 19680727 [TBL] [Abstract][Full Text] [Related]
102. Safety and efficacy of RFA versus MWA for T1a renal cell carcinoma: a propensity score analysis. Aarts BM; Gomez FM; Lopez-Yurda M; Bevers RFM; Herndriks J; Beets-Tan RGH; Bex A; Klompenhouwer EG; van der Meer RW Eur Radiol; 2023 Feb; 33(2):1040-1049. PubMed ID: 36066733 [TBL] [Abstract][Full Text] [Related]
103. Thermal Ablation of T1c Renal Cell Carcinoma: A Comparative Assessment of Technical Performance, Procedural Outcome, and Safety of Microwave Ablation, Radiofrequency Ablation, and Cryoablation. Zhou W; Arellano RS J Vasc Interv Radiol; 2018 Jul; 29(7):943-951. PubMed ID: 29628298 [TBL] [Abstract][Full Text] [Related]
104. Percutaneous microwave ablation of T1a and T1b renal cell carcinoma: short-term efficacy and complications with emphasis on tumor complexity and single session treatment. Wells SA; Wheeler KM; Mithqal A; Patel MS; Brace CL; Schenkman NS Abdom Radiol (NY); 2016 Jun; 41(6):1203-11. PubMed ID: 27167230 [TBL] [Abstract][Full Text] [Related]
105. Long-Term Clinical Outcomes Following Radiofrequency and Microwave Ablation of Renal Cell Carcinoma at a Single VA Medical Center. Abboud SE; Patel T; Soriano S; Giesler J; Alvarado N; Kang P Curr Probl Diagn Radiol; 2018; 47(2):98-102. PubMed ID: 28648469 [TBL] [Abstract][Full Text] [Related]
106. Chyluria after radiofrequency ablation of renal tumors. Kaur H; Matin SF; Javadi S; Johnson VE; Choi H; Sandler C; Ahrar K J Vasc Interv Radiol; 2011 Jul; 22(7):924-7. PubMed ID: 21507680 [TBL] [Abstract][Full Text] [Related]
108. Tumor Growth Kinetics and Oncologic Outcomes of Patients Undergoing Active Surveillance for Residual Renal Tumor following Percutaneous Thermal Ablation. Chen JX; Maass D; Guzzo TJ; Bruce Malkowicz S; Wein AJ; Soulen MC; Clark TWI; Nadolski GJ; William Stavropoulos S J Vasc Interv Radiol; 2016 Sep; 27(9):1397-1406. PubMed ID: 27234485 [TBL] [Abstract][Full Text] [Related]
109. Transarterial embolization (TAE) as add-on to percutaneous radiofrequency ablation (RFA) for the treatment of renal tumors: Review of the literature, overview of state-of-the-art embolization materials and further perspective of advanced image-guided tumor ablation. Sommer CM; Pallwein-Prettner L; Vollherbst DF; Seidel R; Rieder C; Radeleff BA; Kauczor HU; Wacker F; Richter GM; Bücker A; Rodt T; Massmann A; Pereira PL Eur J Radiol; 2017 Jan; 86():143-162. PubMed ID: 28027741 [TBL] [Abstract][Full Text] [Related]
110. Laparoscopic radiofrequency for small renal masses. What is the best imaging technique? Gallego Vilar D; Cifrian García M; García Fadrique G; García Vila J; Gallego Gómez J Arch Esp Urol; 2013; 66(1):60-70. PubMed ID: 23406801 [TBL] [Abstract][Full Text] [Related]
113. R.E.N.A.L. (Radius, exophytic/endophytic, nearness to collecting system or sinus, anterior/posterior, and location relative to polar lines) nephrometry score predicts early tumor recurrence and complications after percutaneous ablative therapies for renal cell carcinoma: a 5-year experience. Camacho JC; Kokabi N; Xing M; Master VA; Pattaras JG; Mittal PK; Kim HS J Vasc Interv Radiol; 2015 May; 26(5):686-93. PubMed ID: 25769213 [TBL] [Abstract][Full Text] [Related]
114. Radiofrequency Ablation of T1a Renal Cell Carcinomas within Renal Transplant Allografts: Oncologic Outcomes and Graft Viability. Cool DW; Kachura JR J Vasc Interv Radiol; 2017 Dec; 28(12):1658-1663. PubMed ID: 28916346 [TBL] [Abstract][Full Text] [Related]
115. Local Recurrence of Renal Cancer After Surgery: Prime Time for Percutaneous Thermal Ablation? Monfardini L; Varano GM; Foà R; Della Vigna P; Bonomo G; Orsi F Cardiovasc Intervent Radiol; 2015 Dec; 38(6):1542-7. PubMed ID: 25902857 [TBL] [Abstract][Full Text] [Related]
116. Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer. Dupuy DE; DiPetrillo T; Gandhi S; Ready N; Ng T; Donat W; Mayo-Smith WW Chest; 2006 Mar; 129(3):738-45. PubMed ID: 16537876 [TBL] [Abstract][Full Text] [Related]
117. Treatment of renal tumors by percutaneous ultrasound-guided radiofrequency ablation using a multitined electrode: effectiveness and complications. del Cura JL; Zabala R; Iriarte JI; Unda M Eur Urol; 2010 Mar; 57(3):459-65. PubMed ID: 19926208 [TBL] [Abstract][Full Text] [Related]
118. Image-Guided Percutaneous Radiofrequency Ablation of Central Renal Cell Carcinoma: Assessment of Clinical Efficacy and Safety in 31 Tumors. Dai Y; Covarrubias D; Uppot R; Arellano RS J Vasc Interv Radiol; 2017 Dec; 28(12):1643-1650. PubMed ID: 28673657 [TBL] [Abstract][Full Text] [Related]